Literature DB >> 15979338

Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue.

Thomas Kislinger1, Anthony O Gramolini, David H MacLennan, Andrew Emili.   

Abstract

An optimized analytical expression profiling strategy based on gel-free multidimensional protein identification technology (MudPIT) is reported for the systematic investigation of biochemical (mal)-adaptations associated with healthy and diseased heart tissue. Enhanced shotgun proteomic detection coverage and improved biological inference is achieved by pre-fractionation of excised mouse cardiac muscle into subcellular components, with each organellar fraction investigated exhaustively using multiple repeat MudPIT analyses. Functional-enrichment, high-confidence identification, and relative quantification of hundreds of organelle- and tissue-specific proteins are achieved readily, including detection of low abundance transcriptional regulators, signaling factors, and proteins linked to cardiac disease. Important technical issues relating to data validation, including minimization of artifacts stemming from biased under-sampling and spurious false discovery, together with suggestions for further fine-tuning of sample preparation, are discussed. A framework for follow-up bioinformatic examination, pattern recognition, and data mining is also presented in the context of a stringent application of MudPIT for probing fundamental aspects of heart muscle physiology as well as the discovery of perturbations associated with heart failure.

Entities:  

Mesh:

Year:  2005        PMID: 15979338     DOI: 10.1016/j.jasms.2005.02.015

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  37 in total

1.  Nuclear membrane proteins with potential disease links found by subtractive proteomics.

Authors:  Eric C Schirmer; Laurence Florens; Tinglu Guan; John R Yates; Larry Gerace
Journal:  Science       Date:  2003-09-05       Impact factor: 47.728

Review 2.  Mass spectral analysis in proteomics.

Authors:  John R Yates
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

3.  Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms.

Authors:  Ahna R Skop; Hongbin Liu; John Yates; Barbara J Meyer; Rebecca Heald
Journal:  Science       Date:  2004-05-27       Impact factor: 47.728

Review 4.  Current two-dimensional electrophoresis technology for proteomics.

Authors:  Angelika Görg; Walter Weiss; Michael J Dunn
Journal:  Proteomics       Date:  2004-12       Impact factor: 3.984

Review 5.  Phospholamban: protein structure, mechanism of action, and role in cardiac function.

Authors:  H K Simmerman; L R Jones
Journal:  Physiol Rev       Date:  1998-10       Impact factor: 37.312

Review 6.  Molecular genetics and genomics of heart failure.

Authors:  Choong-Chin Liew; Victor J Dzau
Journal:  Nat Rev Genet       Date:  2004-11       Impact factor: 53.242

Review 7.  New therapies in sickle cell disease.

Authors:  Elliott Vichinsky
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 9.  Genomics, proteomics and bioinformatics of human heart failure.

Authors:  C G Dos Remedios; C C Liew; P D Allen; R L Winslow; J E Van Eyk; M J Dunn
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

Review 10.  Heart disease, clinical proteomics and mass spectrometry.

Authors:  Brian A Stanley; Rebekah L Gundry; Robert J Cotter; Jennifer E Van Eyk
Journal:  Dis Markers       Date:  2004       Impact factor: 3.434

View more
  29 in total

1.  Synthetic peptide arrays for pathway-level protein monitoring by liquid chromatography-tandem mass spectrometry.

Authors:  Johannes A Hewel; Jian Liu; Kento Onishi; Vincent Fong; Shamanta Chandran; Jonathan B Olsen; Oxana Pogoutse; Mike Schutkowski; Holger Wenschuh; Dirk F H Winkler; Larry Eckler; Peter W Zandstra; Andrew Emili
Journal:  Mol Cell Proteomics       Date:  2010-05-13       Impact factor: 5.911

2.  Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis.

Authors:  James A Madsen; Victor Farutin; Theresa Carbeau; Steve Wudyka; Yan Yin; Stephen Smith; James Anderson; Ishan Capila
Journal:  MAbs       Date:  2015-08-20       Impact factor: 5.857

3.  Online Peptide fractionation using a multiphasic microfluidic liquid chromatography chip improves reproducibility and detection limits for quantitation in discovery and targeted proteomics.

Authors:  Christoph Krisp; Hao Yang; Remco van Soest; Mark P Molloy
Journal:  Mol Cell Proteomics       Date:  2015-04-07       Impact factor: 5.911

Review 4.  Multiplexed protein measurement: technologies and applications of protein and antibody arrays.

Authors:  Stephen F Kingsmore
Journal:  Nat Rev Drug Discov       Date:  2006-04       Impact factor: 84.694

Review 5.  Mass spectrometry based proteomics in urine biomarker discovery.

Authors:  Dan Theodorescu; Harald Mischak
Journal:  World J Urol       Date:  2007-08-17       Impact factor: 4.226

6.  Data Self-Recalibration and Mixture Mass Fingerprint Searching (DASER-MMF) to enhance protein identification within complex mixtures.

Authors:  Ryan M Danell; Severine A Ouvry-Patat; Cameron O Scarlett; J Paul Speir; Christoph H Borchers
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-20       Impact factor: 3.109

7.  Proteomic profiling of recombinant cells from large-scale mammalian cell culture processes.

Authors:  Paula Meleady
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

8.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

9.  Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps.

Authors:  Ruth Isserlin; Daniele Merico; Rasoul Alikhani-Koupaei; Anthony Gramolini; Gary D Bader; Andrew Emili
Journal:  Proteomics       Date:  2010-03       Impact factor: 3.984

10.  Modern approaches to understanding stress and disease susceptibility: A review with special emphasis on respiratory disease.

Authors:  Palok Aich; Andrew A Potter; Philip J Griebel
Journal:  Int J Gen Med       Date:  2009-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.